205 related articles for article (PubMed ID: 24853427)
1. The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption.
Lee MW; Bassiouni R; Sparrow NA; Iketani A; Boohaker RJ; Moskowitz C; Vishnubhotla P; Khaled AS; Oyer J; Copik A; Fernandez-Valle C; Perez JM; Khaled AR
Cell Death Dis; 2014 May; 5(5):e1249. PubMed ID: 24853427
[TBL] [Abstract][Full Text] [Related]
2. Rational development of a cytotoxic peptide to trigger cell death.
Boohaker RJ; Zhang G; Lee MW; Nemec KN; Santra S; Perez JM; Khaled AR
Mol Pharm; 2012 Jul; 9(7):2080-93. PubMed ID: 22591113
[TBL] [Abstract][Full Text] [Related]
3. Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide.
Bassiouni R; Nemec KN; Iketani A; Flores O; Showalter A; Khaled AS; Vishnubhotla P; Sprung RW; Kaittanis C; Perez JM; Khaled AR
Clin Cancer Res; 2016 Sep; 22(17):4366-79. PubMed ID: 27012814
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of Therapeutic Peptide Binding Partners from Isolated Mitochondria.
Mozayan A; Khaled A
Cureus; 2018 Jun; 10(6):e2898. PubMed ID: 30397556
[TBL] [Abstract][Full Text] [Related]
5. PEG-GO@XN nanocomposite suppresses breast cancer metastasis via inhibition of mitochondrial oxidative phosphorylation and blockade of epithelial-to-mesenchymal transition.
Zhang J; Yan L; Wei P; Zhou R; Hua C; Xiao M; Tu Y; Gu Z; Wei T
Eur J Pharmacol; 2021 Mar; 895():173866. PubMed ID: 33454376
[TBL] [Abstract][Full Text] [Related]
6. PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.
Flores O; Santra S; Kaittanis C; Bassiouni R; Khaled AS; Khaled AR; Grimm J; Perez JM
Theranostics; 2017; 7(9):2477-2494. PubMed ID: 28744329
[TBL] [Abstract][Full Text] [Related]
7. Targeting the actin cytoskeleton: selective antitumor action via trapping PKCɛ.
Foerster F; Braig S; Moser C; Kubisch R; Busse J; Wagner E; Schmoeckel E; Mayr D; Schmitt S; Huettel S; Zischka H; Mueller R; Vollmar AM
Cell Death Dis; 2014 Aug; 5(8):e1398. PubMed ID: 25165884
[TBL] [Abstract][Full Text] [Related]
8. Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer.
Liu G; Kim H; Wang P; Fricke DR; Chen H; Wang T; Shen Q; Zhou J
Eur J Med Chem; 2021 Jul; 219():113427. PubMed ID: 33845235
[TBL] [Abstract][Full Text] [Related]
9. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.
Hou L; Zhao X; Wang P; Ning Q; Meng M; Liu C
PLoS One; 2013; 8(1):e53491. PubMed ID: 23326440
[TBL] [Abstract][Full Text] [Related]
11. Polyphyllin I induces mitophagic and apoptotic cell death in human breast cancer cells by increasing mitochondrial PINK1 levels.
Li GB; Fu RQ; Shen HM; Zhou J; Hu XY; Liu YX; Li YN; Zhang HW; Liu X; Zhang YH; Huang C; Zhang R; Gao N
Oncotarget; 2017 Feb; 8(6):10359-10374. PubMed ID: 28060722
[TBL] [Abstract][Full Text] [Related]
12. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
[TBL] [Abstract][Full Text] [Related]
13. [Hirsutine induces apoptosis of human breast cancer MDA-MB-231 cells through mitochondrial pathway].
Huang QW; Zhai NN; Huang T; Li DM
Sheng Li Xue Bao; 2018 Feb; 70(1):40-46. PubMed ID: 29492513
[TBL] [Abstract][Full Text] [Related]
14. Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics.
Qin Y; Chen K; Gu W; Dong X; Lei R; Chang Y; Bai X; Xia S; Zeng L; Zhang J; Ma S; Li J; Li S; Xing G
J Nanobiotechnology; 2018 Jun; 16(1):54. PubMed ID: 29935539
[TBL] [Abstract][Full Text] [Related]
15. Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics.
Brandhagen BN; Tieszen CR; Ulmer TM; Tracy MS; Goyeneche AA; Telleria CM
BMC Cancer; 2013 Jan; 13():35. PubMed ID: 23351358
[TBL] [Abstract][Full Text] [Related]
16. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
17. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas.
Sulaiman MK; Chu Z; Blanco VM; Vallabhapurapu SD; Franco RS; Qi X
Mol Cancer; 2015 Apr; 14():78. PubMed ID: 25889084
[TBL] [Abstract][Full Text] [Related]
18. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
[TBL] [Abstract][Full Text] [Related]
19. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
20. Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro.
Moon D; McCormack D; McDonald D; McFadden D
J Surg Res; 2013 Apr; 180(2):208-15. PubMed ID: 22572619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
